Samuel Whiting - Jul 2, 2024 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
Stock symbol
TPST
Transactions as of
Jul 2, 2024
Transactions value $
$9,951
Form type
4
Date filed
7/3/2024, 07:35 PM
Previous filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPST Common Stock Purchase $9.95K +4.67K +95.33% $2.13 9.57K Jul 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,000 shares acquired under the Issuer's stock purchase plan.